[Results of supratentorial low-grade XXXX --effects of combined radiochemotherapy].

@entity1 @entity57433 @entity5 @entity4175 @entity51 @entity16229 @entity816 @entity512
The retrospective analysis of 53 cases with supratentorial low-grade (grade 1 or 2 due to WHO grading) @entity816 included the years 1965-84. The 5-year and 10-year survival rates were 61.9% and 52.1%, respectively. The recurrence of @entity5 occurred in 15 cases (28.3%), almost within 3 years after the initial treatment, and early recurrent cases indicated poor results. Among them, 6 cases were noticed increasing @entity5 of histological findings. According to our investigations, the factors which influence to the survival rate were age of @entity1 , duration of symptoms before treatment, presence of @entity51 and @entity5 . The @entity1 with good prognosis were under 20-year old, over 6 months of duration, with no neurological signs and with @entity512 . But, 5-year survival rate was not so improved by postoperative radiation therapy. Analysis on the effects of chemotherapy for low-grade @entity816 was little reported. We treated 26 @entity1 with RAFP therapy (Radiation + @entity4175 + @entity16229 + @entity57433 ). Only 2 cases out of 26 showed the recurrence till now. The rate of @entity5 was 46.2% by CT scan. So, it was considered that RAFP therapy was effective for supratentorial low-grade @entity816 .
